Boston Scientific (BSX) Misses Q4 EPS by 2c; Guides
Tweet
Share
E-mail
Get Alerts BSX Hot Sheet
Price: $44.33 -2.12%
EPS Growth %: +10.7%
Financial Fact:
Net income (loss) per common share - assuming dilution: 0.17
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +10.7%
Financial Fact:
Net income (loss) per common share - assuming dilution: 0.17
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Boston Scientific (NYSE: BSX) reported Q4 EPS of $0.45, $0.02 worse than the analyst estimate of $0.47. Revenue for the quarter came in at $3.24 billion versus the consensus estimate of $3.24 billion.
GUIDANCE:
Boston Scientific sees Q1 2023 EPS of $0.42-$0.44, versus the consensus of $0.44.
Boston Scientific sees FY2023 EPS of $1.86-$1.93, versus the consensus of $1.93.
For earnings history and earnings-related data on Boston Scientific (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- AeroVironment restates quarterly financials, citing $89M goodwill error
- Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
